Venditti, A., Piciocchi, A., Candoni, A., Melillo, L., Calafiore, V., Cairoli, R., et al. (2017). RISK-ADAPTED, MRD-DIRECTED THERAPY FOR YOUNG ADULTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: RESULTS OF THE AML1310 TRIAL OF THE GIMEMA GROUP. Intervento presentato a: 22nd Congress of the European-Hematology-Association - JUN 22-25, 2017, Madrid, SPAIN.

RISK-ADAPTED, MRD-DIRECTED THERAPY FOR YOUNG ADULTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: RESULTS OF THE AML1310 TRIAL OF THE GIMEMA GROUP

Cairoli, R;
2017

paper
Hematology
English
22nd Congress of the European-Hematology-Association - JUN 22-25, 2017
2017
2017
102
S2
6
7
S111
none
Venditti, A., Piciocchi, A., Candoni, A., Melillo, L., Calafiore, V., Cairoli, R., et al. (2017). RISK-ADAPTED, MRD-DIRECTED THERAPY FOR YOUNG ADULTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: RESULTS OF THE AML1310 TRIAL OF THE GIMEMA GROUP. Intervento presentato a: 22nd Congress of the European-Hematology-Association - JUN 22-25, 2017, Madrid, SPAIN.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/409796
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 5
Social impact